Literature DB >> 16282463

The cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies.

Kevin C Yim1, Clifford J Carroll, Ana Tuyama, Natalia Cheshenko, Maria Josefina Carlucci, David D Porter, Gregory A Prince, Betsy C Herold.   

Abstract

Prevention of genital herpes and other sexually transmitted infections (STI) is a critical health priority because of the overwhelming impact on women and infants and the epidemiological association with human immunodeficiency virus (HIV)/AIDS. Small animal models are essential for evaluating strategies for prevention or treatment of STI. Neither the murine nor the guinea pig model of genital herpes fully recapitulates human disease. We demonstrate that herpes simplex virus type 2 (HSV-2) readily infects inbred cotton rats (Sigmodon hispidus). Consistent infection does not require pretreatment with medroxyprogesterone, and primary disease resembles that observed in humans. The animals develop genital lesions and fully recover. During primary infection, viral DNA is also detected in liver, lungs, brain, and kidneys. Clinical self-limited recurrences occur spontaneously but may also be induced by dexamethasone. Pretreatment of cotton rats with PRO 2000 gel, a candidate vaginal microbicide being evaluated in clinical trials to prevent HSV and HIV, protects cotton rats from HSV. Together, these studies suggest that the cotton rat may provide an excellent model to study genital herpes and to evaluate preventive strategies.

Entities:  

Mesh:

Year:  2005        PMID: 16282463      PMCID: PMC1287570          DOI: 10.1128/JVI.79.23.14632-14639.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  The cotton rat: an underutilized animal model for human infectious diseases can now be exploited using specific reagents to cytokines, chemokines, and interferons.

Authors:  Jorge C G Blanco; Lioubov Pletneva; Marina Boukhvalova; Joann Y Richardson; Katie A Harris; Gregory A Prince
Journal:  J Interferon Cytokine Res       Date:  2004-01       Impact factor: 2.607

Review 2.  Prevention of herpes simplex virus type 2 transmission with antiviral therapy.

Authors:  Lawrence Corey; Rhoda Ashley
Journal:  Herpes       Date:  2004-08

3.  The interaction between herpes simplex virus and human immunodeficiency virus.

Authors:  Connie L Celum
Journal:  Herpes       Date:  2004-04

4.  Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease.

Authors:  L R Stanberry; E R Kern; J T Richards; T M Abbott; J C Overall
Journal:  J Infect Dis       Date:  1982-09       Impact factor: 5.226

5.  Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2.

Authors:  Amy E Gillgrass; Ali A Ashkar; Kenneth L Rosenthal; Charu Kaushic
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  Intravaginal administration of herpes simplex virus type 2 to mice leads to infection of several neural and extraneural sites.

Authors:  Margaret B Parr; Earl L Parr
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

7.  In vivo role of nectin-1 in entry of herpes simplex virus type 1 (HSV-1) and HSV-2 through the vaginal mucosa.

Authors:  Melissa M Linehan; Susan Richman; Claude Krummenacher; Roselyn J Eisenberg; Gary H Cohen; Akiko Iwasaki
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Inhibition of Neisseria gonorrhoeae genital tract infection by leading-candidate topical microbicides in a mouse model.

Authors:  Steven E Spencer; Iris E Valentin-Bon; Kevin Whaley; Ann E Jerse
Journal:  J Infect Dis       Date:  2004-01-20       Impact factor: 5.226

9.  Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread.

Authors:  Natalia Cheshenko; Marla J Keller; Veronica MasCasullo; Gary A Jarvis; Hui Cheng; Minnie John; Jin-Hua Li; Kathleen Hogarty; Robert A Anderson; Donald P Waller; Lourens J D Zaneveld; Albert T Profy; Mary E Klotman; Betsy C Herold
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 10.  The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics.

Authors:  Lawrence Corey; Anna Wald; Connie L Celum; Thomas C Quinn
Journal:  J Acquir Immune Defic Syndr       Date:  2004-04-15       Impact factor: 3.731

View more
  17 in total

1.  BCG vaccination in the cotton rat (Sigmodon hispidus) infected by the pulmonary route with virulent Mycobacterium tuberculosis.

Authors:  Christine T McFarland; Lan Ly; Amminikutty Jeevan; Toshiko Yamamoto; Bradley Weeks; Angelo Izzo; David McMurray
Journal:  Tuberculosis (Edinb)       Date:  2010-05-06       Impact factor: 3.131

2.  Alternatives to retroorbital blood collection in hispid cotton rats (Sigmodon hispidus).

Authors:  Jessica D Ayers; Paul A Rota; Marcus L Collins; Clifton P Drew
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-03       Impact factor: 1.232

3.  Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model.

Authors:  Marina Boukhvalova; Jamall McKay; Aissatou Mbaye; Hannah Sanford-Crane; Jorge C G Blanco; Ashley Huber; Betsy C Herold
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

4.  Current status and prospects for development of an HSV vaccine.

Authors:  Christine Johnston; David M Koelle; Anna Wald
Journal:  Vaccine       Date:  2013-09-06       Impact factor: 3.641

5.  Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection.

Authors:  Jill M Steinbach; Caroline E Weller; Carmen J Booth; W Mark Saltzman
Journal:  J Control Release       Date:  2012-06-15       Impact factor: 9.776

Review 6.  HSV-2: in pursuit of a vaccine.

Authors:  Christine Johnston; David M Koelle; Anna Wald
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

Review 7.  Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?

Authors:  Gargi Dasgupta; Lbachir BenMohamed
Journal:  Vaccine       Date:  2011-06-28       Impact factor: 3.641

Review 8.  The challenge of developing a herpes simplex virus 2 vaccine.

Authors:  Lesia K Dropulic; Jeffrey I Cohen
Journal:  Expert Rev Vaccines       Date:  2012-12       Impact factor: 5.217

9.  Nitric oxide production and nitric oxide synthase type 2 expression by cotton rat (Sigmodon hispidus) macrophages reflect the same pattern as human macrophages.

Authors:  Mary Carsillo; Vijay Kumar Kutala; Karen Puschel; Jorge Blanco; Periannan Kuppusamy; Stefan Niewiesk
Journal:  Dev Comp Immunol       Date:  2009-01-18       Impact factor: 3.636

10.  Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection.

Authors:  Jorge C G Blanco; Lioubov M Pletneva; Lindsay Wieczorek; Dimple Khetawat; Tzanko S Stantchev; Christopher C Broder; Victoria R Polonis; Gregory A Prince
Journal:  Virol J       Date:  2009-05-14       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.